Cost-effectiveness of TNF-α-blocking agents in the treatment of rheumatoid arthritis

Author： Merkesdal Sonja   Ruof Jörg   Mittendorf Thomas   Zeidler Henning  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.9, 2004-09, pp. : 1881-1886

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The use of TNF-α blocking agents in rheumatoid arthritis: an overview

By Toussirot Éric   Wendling Daniel  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. : 581-594

Informa Healthcare

Access to resources Recommend Favorite

TNF-α antagonists cost effective for rheumatoid arthritis

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 538, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Tumour Necrosis Factor-α Inhibitors as First-Line Agents in Rheumatoid Arthritis

By Spalding James R.  

PharmacoEconomics, Vol. 24, Iss. 12, 2006-01 ,pp. : 1221-1232

Adis International

Access to resources Recommend Favorite

Anti-TNF Treatment in Rheumatoid Arthritis

By  

Current Pharmaceutical Design, Vol. 17, Iss. 29, 2011-10 ,pp. : 3141-3151

Bentham Science Publishers

Access to resources Recommend Favorite

The Cost Effectiveness of Infliximab for Severe Treatment-Resistant Rheumatoid Arthritis in the UK

By Barbieri Marco  

PharmacoEconomics, Vol. 23, Iss. 6, 2005-01 ,pp. : 607-618

Adis International

Access to resources Recommend Favorite